本文選題：卵巢刺激　切入點(diǎn)：輔助生殖技術(shù)　出處：《實(shí)用婦產(chǎn)科雜志》2017年05期

【摘要】：正根據(jù)世界衛(wèi)生組織的報(bào)道,不孕癥患者比例逐年攀升,目前已高達(dá)6%~10%。輔助生殖技術(shù)是目前治療不孕癥的主要技術(shù),其中控制性卵巢刺激技術(shù)的完善和發(fā)展大幅提高了卵母細(xì)胞的獲取數(shù)量,但該技術(shù)也存在誘發(fā)生殖系統(tǒng)激素依賴性腫瘤的可能,所以,控制性卵巢刺激過(guò)程中存在的長(zhǎng)期安全性問(wèn)題目前
[Abstract]:According to the report of the World Health Organization, the proportion of infertile patients has increased year by year, and at present it has reached as high as 610. Assistive reproductive technology is the main technology for the treatment of infertility at present. Among them, the improvement and development of controlled ovarian stimulation technology has greatly increased the number of oocytes obtained, but this technique also has the possibility of inducing hormone dependent tumors in the reproductive system, so, Long-term Safety problems during controlled Ovarian stimulation
【作者單位】： 西北婦女兒童醫(yī)院;
【分類號(hào)】：R714.8;R737.3

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 Laven JS;Fauser BC;菅鑫妍;;雌激素在卵巢刺激中的作用[J];中國(guó)處方藥;2006年09期

2 王Z，

本文編號(hào)：1690442